Differential development of oil granulomas induced by pristane injection in galectin-3 deficient mice
© Brand et al. 2015
Received: 4 September 2015
Accepted: 6 November 2015
Published: 14 November 2015
Galectin-3 is known to be a lectin that plays an important role in inflammatory processes, acting as pro-inflammatory mediator in activation and migration of neutrophils and macrophages, as well as in the phagocytic function of these cells. The injection of mineral oils into the peritoneal cavity of mice, such as 2, 6, 10, 14-tetramethylpentadecane (pristane), induce a chronic granulomatous inflammatory reaction which is rich in macrophages, B cells and peritoneal plasma cells known as oil granuloma. In addition, this inflammatory microenvironment provided by oil granulomas is also an important site of plasmacytoma induction, which are dependent on cytokine production and cellular mobilization.
Here, we have analyzed the role of galectin-3 in inflammatory cells mobilization and organization after pristane injection characterizing granulomatous reaction through the formation of oil granulomas.
In galectin-3 deficient mice (gal-3−/−), the mobilization of inflammatory cells, between peritoneal cavity and bone marrow, was responsible for the formation of disorganized oil granulomas, which presented scattered cells, large necrotic areas and low amounts of extracellular matrix. The production of inflammatory cytokines partially explained the distribution of cells through peritoneal cavity, since high levels of IL-6 in gal-3−/− mice led to drastically reduction of B1 cells. The previous pro-inflammatory status of these animals also explains the excess of cell death and disruption of oil granulomas architecture.
Our data indicate, for the first time, that the disruption in the inflammatory cells migration in the absence of galectin-3 is a crucial event in the formation and organization of oil granulomas.
KeywordsPristane Oil granuloma Bone marrow Peritoneal cavity Inflammation
Chronic inflammation represents a heterogeneous group of physiological conditions that may affect virtually any organ or system. Histologically, the chronic inflammation exhibits a predominance of mononuclear cells, such as macrophages, lymphocytes and plasma cells. In contrast, neutrophils are relevant for the initial phases of the inflammatory process [1, 2]. The stromal milieu (cellular and matrix components) regulates leukocyte production and recruitment from the bone marrow to the site of the inflammatory stimulus, determining the outcome of the process. However, the production of bone marrow cells, including neutrophils, is also largely regulated by the rate of apoptosis of hematopoietic cells in the site of inflammation in a T cell dependent-manner [3, 4].
In this context, continuous and unbalanced recruitment of inflammatory cells such as neutrophils, monocytes, lymphocytes and dendritic cells, from the bone marrow or adjacent tissues, toward the chronic site of stimulus can be determinant to the development of several immune responses .
Chronic inflammation can be triggered by long-lasting exposure to naturally occurring hydrocarbon oils such as pristane (2, 6, 10, 14-tetramethylpentadecane, TMPD) , which is not metabolized and causes severe physiological consequences to mammals . Although, the clinical significance of these lesions in the development of an infection or neoplasia remains unknown. Epidemiologic studies suggest that occupational exposure to hydrocarbon oils or petroleum waste is associated to rheumatoid arthritis and systemic lupus erythematous [8, 9]. In experimental mouse models, pristane induces a continuous intraperitoneal chronic inflammation followed by oil-granuloma formation and plasma cell tumors, known as plasmacytoma [10–12]. These granulomas are frequently adhered to peritoneal structures correlated to vigorous immune response, autoantibody production and clinical manifestations resembling systemic lupus erythematous .
Pristane-induced granulomas are characterized by individual and clustered cells adhered to the mesentery  and other peritoneal tissues often covered by mesothelial cells. Angiogenesis in these structures is also established by terminal mesenteric vessels. Moreover, the structure of oil granulomas is regulated by several cytokines, such as IL-6, IFNs, IL-2 and TNF-α [7, 15–17]. These oil granulomas are considered tertiary lymphoid tissues and are enriched by terminally differentiated plasma cells, macrophages and resident self-renewing peritoneal B-1 lymphocytes. In addition, they may be putative targets to understand plasmacytoma development [11, 18]. Although oil granulomas have been well characterized, the role of the first recruited cells to the peritoneal microenvironment and their participation in the organization of the granuloma are not well understood.
Galectin-3, a β-galactoside binding protein, modulates both chronic inflammation and fibrogranulomatous reaction , regulating cell-cell and cell-extracellular matrix interactions in healthy and pathological conditions [20–23]. Galectin-3 deficient mice (Gal-3−/− mice) have a delayed monocyte differentiation into macrophages and neutrophil mobilization . On the other hand, these mice have a significant plasmacytogenesis in secondary lymphoid tissues. In addition, the mesenteric membranes histologically correlated with disturbances in B lymphocyte and plasma cell niches [25–27].
In this study, we investigated the histological organization of pristane-induced oil granulomas in the absence of galectin-3. The kinect of cell mobilization and oil granuloma formation were analyzed in different time points of the inflammatory process. In the absence of galectin-3, the organization of oil granulomas was dependent on both bone marrow and peritoneal cavity cells, leading to a necrotic tissue, extracellular matrix disruption and disorganized cellular distribution. On the other hand, oil granulomas formed in the presence of galectin-3, did not present intense cell death, favoring maintenance and amplification of hematopoietic cells, mainly granulocytes.
Cellularity in galectin-3−/− mice is influenced by pristane injection and affects lymphocyte subpopulations
Lymphoid compartment along pristane injection presented differences in CD4+ and CD8+ T lymphocyte populations, both in bone marrow and peritoneal cavity. In the absence of gal-3, CD5 + CD4+ T cells were drastically reduced in bone marrow at 60 days after pristane injection (Fig. 1c and d). However, this cell population was not observed in peritoneal cavity, where CD5 + CD4+ T lymphocytes presented an initial decrease at day 7, but recovered at day 60 to initial numbers compared to gal-3−/− control mice (Fig. 1d). On the other hand, CD5 + CD8+ T lymphocytes presented an opposite behavior, with initial increase, and then, returning to initial total values after 60 days when compared to control group (Fig. 1e). In contrast to gal-3−/−, WT animals presented an increase in CD5 + CD4+ T lymphocytes in bone marrow (Fig. 1c), accompanied by the increase of this population in the peritoneal cavity (Fig. 1d). However, no significant difference was observed in bone marrow CD5 + CD8+ T cells (Fig. 1e). In peritoneal cavity, CD5 + CD8+ T cells behavior was similar to that observed in gal-3−/− mice (Fig. 1f).
The pattern of granulocyte response is modified in the absence of galectin-3 and influences the oil granuloma composition
As described above, the increased number of GrlowCD11bhi myeloid progenitor cells and GrhiCD11bhi mature myeloid cells in the peritoneal cavity of WT mice (Fig. 3b and d, respectivelly) could reflect the cellular composition of oil granulomas in these mice. Indeed, Fig. 3e shows an intense presence of polymorphonuclear cells foci (arrows and insert), indicating a peripheral amplification inside the inflammatory site, in a time independent manner from the bone marrow production. In gal-3−/− mice, oil granulomas were composed mainly by mononuclear cells, without the organization of polymorphonuclear foci (Fig. 3f, arrowheads and insert).
Galectin-3 in granulomas induced by pristane differentially organizes cellular and extracellular components
Oil granulomas in WT animals, macroscopically examined at 60 days after pristane injection (Fig. 4a, white arrows), exhibited two distinct regions when histologically observed: a highly cellular cortical region (Fig. 4c, above dotted line) and an inner region less cellular, but rich in lipid material. The granulomas presented several blood vessels (Fig. 4c, red circles, and e), in many instances structured with a muscular tunica (Fig. 4e, insert). Macroscopic structures of gal-3−/− mice oil granulomas were also obtained (Fig. 4b, white arrows). However, we did not observe a clear compartmentalization of the oil granulomas formed in gal-3−/− mice. Instead, cells were randomly distributed, with blood vessels surrounded by inflammatory cells (Fig. 4d and f, arrowheads). Presence of blood vessels was confirmed by CD31 immunolocalization, as demonstrated in Fig. 4g and h. In WT mice, we observed a higher quantity of blood vessels, as observed in Fig. 4i, when compared to gal-3−/− animals. These results suggest a favoring of cell mobilization process from both bone marrow and peritoneal cavity.
We took advantage of the higher resolution of TEM to study the ultrastructure of granulomas. As previously observed, WT mice oil granulomas presented a large amount of randomly distributed collagen fibrils (Fig. 5c and e, black arrows). On the other hand, we observed by TEM the presence of large amounts of necrotic tissues and dispersed ECM in oil granulomas from gal-3−/−animals (Fig. 5d, white arrows). Furthermore, a drastic reduction in the amount of collagen fibrils was observed. They were dispersed in small quantities in the necrotic tissue, as demonstrated by trichrome staining (Fig. 5f, black arrows).
These data indicate that cellular and extracellular matrix composition inside inflammatory site of oil granulomas could negatively regulate bone marrow response, favoring a peripheral cellular amplification that may lead to different consequences to the outcome of the inflammatory process.
The initial profile of cytokines produced by adherent peritoneal cells is the major responsible for the input of the inflammatory response
As we observed a drastic reduction of B lymphocytes in the absence of galectin-3, both in bone marrow and peritoneal cavity, and a differential oil granuloma organization between WT and gal-3−/− mice, we investigated the expression of major pro-inflammatory cytokines by adherent peritoneal cavity cells. For this, we injected pristane in WT and gal-3−/− mice and at 48 h or at 7 days we quantified cytokine mRNA levels expressed by the cells in the peritoneal cavity.
Macrophage inflammatory protein 2 (MIP-2), a cytokine related to neutrophil recruitment, was also analyzed. As we can observe in Fig. 7d, WT mice presented a down regulation of the mRNA levels at 48 h after pristane inoculation. In contrast, there was no significant difference in the mRNA levels in gal-3−/−. Curiously, when we compared the expression levels of mRNA of MIP-2 between WT and gal-3−/− mice, this cytokine was more expressed in the absence of galectin-3 (Fig. 7d).
Expression of cytokines related to macrophage polarization, arginase and inducible nitric oxide synthase (iNOS), were analyzed in peritoneal adherent cells (Fig. 7e and f, respectivelly). Arginase expression presented the same pattern in WT and gal-3−/− mice, increasing expression after 48 h of pristane stimulus, maintaining these levels increased until 7 days. However, this increase was significantly greater in the absence of galectin-3 when compared to WT animals (Fig. 7e). On the other hand, iNOS expression was not altered both in WT and gal-3−/− mice during treatment. However, expression levels of iNOS in the absence of galectin-3 were increased in all time points analyzed when compared to WT animals (Fig. 7f).
In this study, our results indicate, for the first time, that differential granulomatous reaction and its components, including the presence of cellular debris, regulate mobilization and amplification of inflammatory cells from the bone marrow to the initial site of inflammation.
As observed in our data, oil granulomas formed in WT mice presented greater amounts of neutrophils distributed though parenchyma, followed by a very well organized structure, rich in blood vessels and a scaffold of connective tissue formed by collagen. As described in the literature [7, 28] these structures are formed by large amounts of lipid material, surrounded by inflammatory cells organized as lymphoid follicles, e.g., B lymphocytes nodules surrounded by T and dendritic cells. However, our data showed an intense infiltration of granulocytic cells in WT mice. These conflicting data may be due to the time frame after pristane stimulus chosen to be analyzed. Indeed, Nacionales’ group performed their analysis at least 12 weeks after pristane stimulus , whereas we analyzed after 8 weeks, using the same mice strain, eliminating possible genetic background influence. However, Chen et al. demonstrated that genetic background contributes to organization and composition of oil granulomas, raising conflicting data in the literature [14, 28]. Thus, both time frame and genetic background can influence separately or synergistically the development of oil granulomas.
On the other hand, oil granulomas formed in gal-3−/− animals were mainly composed by mononuclear cells, including B and T lymphocytes, and reduced amounts of neutrophils. These structures presented low vascularization and ECM, which likely promoted intense cell death. The reduced amounts of neutrophils in peritoneal cavity of gal-3−/− mice could reflect the delay in myeloid cell maturation  or a delayed migration from the bone marrow , as described in the literature. Schauer and Gresnigt groups have described an important role of neutrophils in resolution of the inflammatory process by reducing proinflammatory cytokines production [29, 30]. In view of these results, it is important to analyze in our model the role of neutrophils in late stages of pristane-induced inflammation and their outcome to plasmacytoma and/or autoimmune diseases development.
The observation of an increase in the expression levels of MIP-2 in gal-3−/− mice, an important cytokine involved in neutrophils recruitment [31, 32], suggests that peritoneal macrophages upregulate MIP-2 in an attempt to compensate the reduced recruitment of neutrophils to inflammatory site or the excess of cell death observed in these animals.
Galectin-3 plays an important role as a negative regulator in apoptotic events [26, 33], so that oil granulomas deficient in this lectin presented a great number of cells positively stained for annexin-V, apoptotic cells and great amounts of cell debris. The persistence of apoptotic cells and cell debris in situ could also be a result of low phagocytic state of macrophages, as our group previously described in gal-3−/− mice .
The increase in the expression levels of IL-12 p40 and IL-6 expression is already described in the literature as negative regulator of B1 B lymphocytes . As we observed in our data, in the absence of galectin-3, IL-6 expression in adherent cells was significantly upregulated 7 days after pristane injection. In addition, there was a drastic reduction of B1 lymphocytes in the peritoneal cavity. Interestingly, these same parameters were observed in WT mice only 60 at days after pristane injection. Both IL-6 and IL-12p40 upregulation were observed in WT and gal-3−/− mice. On the other hand, TNF-α down modulation was also observed in WT mice, corroborating data described by Chae and Shin , however, this reduction was more drastic in the absence of galectin-3. Adherent cells of WT mice expressed high levels of arginase and presented no differences in iNOS expression after pristane injection, suggesting polarization of macrophages to an anti-inflammatory M2 phenotype. In the gal-3−/− mice, we also observed polarization to M2 phenotype coupled to unchanged levels of no iNOS expression. However, since these animals have high expression of iNOS in the absence of inflammatory stimulus, we suggest that this initial pro-inflammatory M1 background could disturb the response, maintaining the inflammatory status and promoting a rise in cell death within the oil granulomas.
Bone marrow compartment is a productive site of hematopoietic cells, which are continuously mobilized to the primary site of inflammation, and contribute to the development and organization of oil granulomas. In our model, as expected, bone marrow cellularity clearly increased in WT mice after 60 days of pristane injection. An increased cellularity was also observed in the peritoneal cavity fluid, providing evidence that the bone marrow cells are migrating to the initial site of inflammation. However, galectin-3 deficient mice seem not to respond in the same way to the pristane injection, since the cellularity in both bone marrow and peritoneal cavity of these animals was not altered during the experiments. Despite the increase in the total number of mature neutrophils, both in bone marrow and peritoneal cavity, at 60 days after pristane injection, the total number of granulocytic precursors (GrlowCD11bhi) remained unchanged in bone marrow. On the other hand, these precursors were significantly increased in the peritoneal cavity, suggesting a local amplification of these cells. It likely occurred in oil granulomas and in large scale in WT mice, since we observed greater quantities of mature neutrophils in these animals, and more myeloid clusters inside the oil granulomas.
As related in the literature, pristane can be toxic to cells inducing apoptosis and necrosis [17, 36]. In addition, it can accumulate in hematopoietic organs, like spleen and bone marrow . Our group has previously demonstrated that in the absence of galectin-3, lymph node cells are more susceptible to apoptosis . Bone marrow cells of galectin-3 deficient mice might be more sensitive to pristane toxicity, explaining why cellularity in this organ did not increase.
Our data indicated that the first steps of oil granuloma development, with a local amplification of inflammatory myeloid cells, led to a gradual reduction of bone marrow cells mobilization, turning the local responses more autonomous. In contrast, the altered milieu of oil granulomas (low amount of ECM and high of cell debris) could disturb the bone marrow physiology in an attempt to compensate the absence of peripheral amplification. This altered microenvironment of gal-3−/− oil granulomas could be partially explained by an unbalance of pro and anti-inflammatory cytokines produced by macrophages.
Our next steps are to evaluate the consequences of normal and necrotic oil granulomas in the development of lymphoproliferative diseases such as plasmacytoma, which is classically associated with long lasting chronic inflammatory processes.
Galectin-3 deficient mice (gal-3−/−) were generated as described  and backcrossed to BALB/cJ mice for nine generations. Age and sex matched wild type (WT) mice on BALB/cJ background were used as controls and were obtained from a colony bred at Federal University of São Paulo (Brazil). All mice procedures were performed at Federal University of Rio de Janeiro in accordance with institutional guidelines (protocol number DAHEICB071, Federal University of Rio de Janeiro). To induce inflammatory process, 8–12 weeks-old mice received a single intraperitoneal injection of 500 μL of 2,6,10,14 tetrametyl-pentadecane (pristane) (95 % pure, Sigma-Aldrich, St Louis, MO, USA). After 7 or 60 days, mice were euthanized using a carbon dioxide chamber. Non injected mice were used as controls.
For histological analysis, WT and galectin-3−/− mice were sacrificed 60 days after pristane injection. Several oil granulomas were excised, washed in cold saline, fixed in buffered 10 % formalin for 24 h at 4 °C, embedded in paraffin and sectioned into 4-m thick slices. The slices were dewaxed using xylene, hydrated in a graded ethanol, and then washed with distilled water. Lastly, the slices were processed routinely with hematoxylin & eosin (H&E) or with Masson’s Trichrome stain. For Masson’s Trichrome stain, briefly, slides were placed in Bouin solution for 1 h at 56 °C, then stained with Weigert hematoxylin (10 min; Sigma-Aldrich, St. Louis, MO), followed by Biebrich scarlet acid fuchsin (5 min; Sigma-Aldrich), phosphomolybdic/phosphotungstic acid solution (10 min; Sigma-Aldrich), and aniline blue (5 min; Sigma-Aldrich).
Transmission electron microscopy (TEM)
Oil granulomas were fixed in a solution containing 2.5 % glutaraldehyde, 4 % formaldehyde and 0.1 M sodium phosphate buffer for 4 h at room temperature. Part of the granulomas was cut in two halves to allow the fixative to diffuse faster throughout the granulomas. After rinsing in the same buffer (3 × 10 min), the samples were dehydrated in graded series of acetone till absolute and embedded in epoxy resin (Embed 812). Ultrathin-sections (70 nm) were obtained using a ultramicrotome (Leica) and a diamond knife (Diatome), collected in 300 mesh copper grids and stained with 5 % uranyl acetate for 30 min and 1 % lead citrate for 3 min. The sections were observed in a Zeiss 900 TEM operated at 80 kV and images (2048 × 2048 pixels) acquired using a CCD camera (Olympus).
Paraffin-embedded sections were de-waxed and hydrated. After inhibition of endogenous peroxidase, sections were incubated for 1 h with 0.01 M PBS containing 5 % BSA, 4 % skim milk, 0.1 % Triton X-100 (Sigma Aldrich, USA), 0.05 % Tween-20, and 10 % normal goat serum followed by incubation with purified antibodies overnight at 4 °C in a humid chamber. Primary antibodies were revealed with a biotinylated anti-rat IgG (BA-4001, Vector Laboratories, Burlingame, CA, USA) and developed with avidin-peroxidase (1:200 in PBS) (Sigma Aldrich, USA), using diaminobenzidyne as the chromogen. Sections were counterstained with Harris’ hematoxylin.
Bone marrow cells were obtained ex vivo by flushing the femoral cavity of WT and gal-3−/− mice with phosphate buffered saline (PBS), pH 7.2, with 3 % fetal bovine serum (FBS, LGC; Cotia, São Paulo, Brazil). Peritoneal cells were harvested on cold PBS with 3 % FBS. A pool of oil granulomas was obtained from each animal, and cells were recovered by digesting the tissues with 2 mg/mL type I-A collagenase and 1 mg/mL dispase in DMEM (Sigma-Aldrich) with constant stirring for 1 h at 37 °C. The resulting cell suspension was removed and filtered through fine nylon mesh . Cells were washed, counted and prepared for further experimentation. When indicated, red blood cell lyses were done with hypotonic ACK (ammonium chloride potassium) solution.
In order to saturate Fc receptors, 1 × 106 cells/mL bone marrow, peritoneal and oil granuloma-derived cells were incubated with the Fc blocker antibody, produced by clone 2.4G2 (obtained from the Rio de Janeiro Cell Bank PABCAM, Federal University, Rio de Janeiro, Brazil), for 10 min before adding specific monoclonal antibodies (mAbs). Cells were incubated with mAbs for 30 min; unbound mAbs were washed out with PBS. The following mAbs were used: for T lymphocytes quantification, triple staining was used (FITC-labeled CD8, PE-labeled CD4 and PerCP-labeled CD5); for peritoneal cavity B lymphocytes quantification, double staining was used (FitC-labeled CB11b and APC-labeled B220); for bone marrow B lymphocytes analysis a single staining was used (APC-labeled B220), since there was not observed any double positive (B220+ CD11b+) B1 cells; and for mature and precursor granulocytes analysis a triple staining was used (FitC-labeled CD11b, PerCP-labeled Gr-1 and APC-labeled Ly-6G), where double high positivity for Gr-1 and CD11b was characterized as mature granulocytes, as emphasized by Ly-6G staining, and Gr-1 low and CD11b high cells were characterized as myeloid progenitors. All gating strategies used in this paper are demonstrated in Additional file 1: Figure S1. All antibodies used were obtained from BD Bioscience, San Jose, CA, USA. For cell death analysis, cells were incubated with Annexin-V FITC, according to manufacturer informations (BD Bioscience). Samples were acquired in a flow cytometer (FACScalibur; BD Bioscience) using Cell Quest software and analyzed using WinMDI 2.9 software.
Isolation of adherent peritoneal cells
Animals were divided into four groups with five animals each: (1) WT control group: this group was injected with 500 μL of PBS; (2) WT pristane-treated group: received a single intraperitoneal injection of 500 μL of pristane; (3) gal-3−/− control group: this group was injected with 500 μL of PBS; (4) gal-3−/−pristane-treated group: received a single intraperitoneal injection of 500 μL of pristine. At the end of the experimental period (48 h and 7 days), animals were sacrificed and peritoneal lavage samples were collected by injecting 3 mL of phosphate-buffered saline (PBS). Individual lavage samples were cultured in a 6 well plate at 37 °C with 5 % CO2. After 2 h, peritoneal adherent cells were rinsed with PBS to remove non-adherent cells and subsequently, total RNA was isolated using Tri-Reagent (Sigma).
Total RNA extraction, reverse transcription and quantitative PCR
Primer sequence (5’-3’)
The statistical tests were applied using Tukey’s multiple comparison test (t test) and the significance threshold was fixed for α = 0.05. Therefore, P values ≤0.05 were considered statistically significant.
FAPERJ (E-26/111.411/2013) and CNPq (141799/20129) for financial support.
Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
- Kratz A, Campos-Neto A, Hanson MS, Ruddle NH. Chronic inflammation caused by lymphotoxin is lymphoid neogenesis. J Exp Med. 1996;183:1461–72.View ArticlePubMedGoogle Scholar
- Aloisi F, Pujol-Borrell R. Lymphoid neogenesis in chronic inflammatory diseases. Nat Rev Immunol. 2006;6:205–17.View ArticlePubMedGoogle Scholar
- Von Vietinghoff S, Ley K. IL-17A controls IL-17 F production and maintains blood neutrophil counts in mice. J Immunol. 2009;183:865–73.View ArticleGoogle Scholar
- Borregaard N. Neutrophils, from marrow to microbes. Immunity. 2010;33:657–70.View ArticlePubMedGoogle Scholar
- McGettrick HM, Butler LM, Buckley CD, Rainger GE, Nash GB. Tissue stroma as a regulator of leukocyte recruitment in inflammation. J Leukoc Biol. 2012;91(3):385–400.View ArticlePubMedGoogle Scholar
- Rontani J-F, Bonin P. Production of pristane and phytane in the marine environment: Role of prokaryotes. Res Microbiol. 2011;162:923–33.View ArticlePubMedGoogle Scholar
- Nacionales DC, Kelly KM, Lee PY, Zhuang H, Li Y, Weinstein JS, et al. Type I interferon production by tertiary lymphoid tissue developing in response to 2,6,10,14-tetramethyl-pentadecane (pristane). Am J Pathol. 2006;168:1227–40.PubMed CentralView ArticlePubMedGoogle Scholar
- Sverdrup B, Kallberg H, Bengtsson C, Lundberg I, Padyukov L, Alfredsson L, et al. Association between occupational exposure to mineral oil and rheumatoid arthritis: Results from the Swedish EIRA case–control study. Arthritis Res Ther. 2005;7:R1296–303.PubMed CentralView ArticlePubMedGoogle Scholar
- Dahlgren J, Takhar H, Anderson-Mahoney P, Kotlerman J, Tarr J, Warshaw R. Cluster of systemic lupus erythematosus (SLE) associated with an oil field waste site: A cross sectional study. Environ Health. 2007;6:8.PubMed CentralView ArticlePubMedGoogle Scholar
- Potter M. Neoplastic development in plasma cells. Immunol Rev. 2003;194:177–95.View ArticlePubMedGoogle Scholar
- Potter M, Wiener F. Plasmacytomagenesis in mice: Model of neoplastic development dependent upon chromosomal translocations. Carcinogenesis. 1992;13:1681–97.View ArticlePubMedGoogle Scholar
- Anderson PN, Potter M. Induction of plasma cell tumours in BALB-c mice with 2,6,10,14-tetramethylpentadecane (pristane). Nature. 1969;222:994–5.View ArticlePubMedGoogle Scholar
- Satoh M, Reeves WH. Induction of lupus-associated autoantibodies in BALB/c mice by intraperitoneal injection of pristane. J Exp Med. 1994;180:2341–6.View ArticlePubMedGoogle Scholar
- Chen H, Liao D, Holl TM, Snowden P, Ueda Y, Kelsoe G. Genetic regulation of pristane-induced oil granuloma responses. Int J Exp Pathol. 2010;91:472–83.PubMed CentralView ArticlePubMedGoogle Scholar
- Wu Q., Sun X., Chi R., Xu L., Li X., Feng J. and Chen H. RORgammat modulates macrophage recruitment during a hydrocarbon oil-induced inflammation. PLoS One. 2013;8, e79497Google Scholar
- Reeves WH, Lee PY, Weinstein JS, Satoh M, Lu L. Induction of autoimmunity by pristane and other naturally occurring hydrocarbons. Trends Immunol. 2009;30:455–64.PubMed CentralView ArticlePubMedGoogle Scholar
- Herman S, Kny A, Schorn C, Pfatschbacher J, Niederreiter B, Herrmann M, et al. Cell death and cytokine production induced by autoimmunogenic hydrocarbon oils. Autoimmunity. 2012;45:602–11.View ArticlePubMedGoogle Scholar
- Ishikawa S, Matsushima K. Aberrant B1 cell trafficking in a murine model for lupus. Front Biosci. 2007;12:1790–803.View ArticlePubMedGoogle Scholar
- Li L, Li J, Gao J. Functions of galectin-3 and its role in fibrotic diseases. J Pharmacol Exp Ther. 2014;351:336–43.View ArticlePubMedGoogle Scholar
- Oliveira FL, Frazao P, Chammas R, Hsu DK, Liu FT, Borojevic R, et al. Kinetics of mobilization and differentiation of lymphohematopoietic cells during experimental murine schistosomiasis in galectin-3 −/− mice. J Leukoc Biol. 2007;82:300–10.View ArticlePubMedGoogle Scholar
- Henderson NC, Sethi T. The regulation of inflammation by galectin-3. Immunol Rev. 2009;230:160–71.View ArticlePubMedGoogle Scholar
- Mackinnon A.C., Gibbons M.A., Farnworth S.L., Leffler H., Nilsson U.J., Delaine T., Simpson A.J., Forbes S.J., Hirani N., Gauldie J. and Sethi T. Regulation of transforming growth factor-beta1-driven lung fibrosis by galectin-3. Am J Respir Crit Care Med. 2012;185:537–546Google Scholar
- Hrynchyshyn N, Jourdain P, Desnos M, Diebold B, Funck F. Galectin-3: A new biomarker for the diagnosis, analysis and prognosis of acute and chronic heart failure. Arch Cardiovasc Dis. 2013;106:541–6.View ArticlePubMedGoogle Scholar
- Hsu DK, Yang RY, Pan Z, Yu L, Salomon DR, Fung-Leung WP, et al. Targeted disruption of the galectin-3 gene results in attenuated peritoneal inflammatory responses. Am J Pathol. 2000;156:1073–83.PubMed CentralView ArticlePubMedGoogle Scholar
- Oliveira FL, Chammas R, Ricon L, Fermino ML, Bernardes ES, Hsu DK, et al. Galectin-3 regulates peritoneal B1-cell differentiation into plasma cells. Glycobiology. 2009;19:1248–58.View ArticlePubMedGoogle Scholar
- Oliveira FL, Brand C, Paula AA, Arcanjo KD, Hsu DK, Liu FT, et al. Lack of galectin-3 disturbs mesenteric lymph node homeostasis and B cell niches in the course of Schistosoma mansoni infection. PLoS One. 2011;6:e19216.PubMed CentralView ArticlePubMedGoogle Scholar
- Brand C, Oliveira FL, Takiya CM, Palumbo Jr A, Hsu DK, Liu FT, et al. The involvement of the spleen during chronic phase of Schistosoma mansoni infection in galectin-3−/− mice. Histol Histopathol. 2012;27:1109–20.PubMedGoogle Scholar
- Chen H, Liao D, Cain D, McLeod I, Ueda Y, Guan Z, et al. Distinct granuloma responses in C57BL/6 J and BALB/cByJ mice in response to pristane. Int J Exp Pathol. 2010;91:460–71.PubMed CentralView ArticlePubMedGoogle Scholar
- Gresnigt MS, Joosten LAB, Verschueren I, van der Meer JWM, Netea MG, Dinarello CA, et al. Neutrophil-mediated inhibition of proinflammatory cytokine responses. J Immunol. 2012;189:4806–15.View ArticlePubMedGoogle Scholar
- Schauer C, Janko C, Munoz LE, Zhao Y, Kienhöfer D, Frey B, et al. Aggregated neutrophil extracellular traps limit inflammation by degrading cytokines and chemokines. Nat Med. 2014;20:511–7.View ArticlePubMedGoogle Scholar
- Yan XT, Tumpey TM, Kunkel SL, Oakes JE, Lausch RN. Role of MIP-2 in neutrophil migration and tissue injury in the herpes simplex virus-1-infected cornea. Invest Ophthalmol Vis Sci. 1998;39:1854–62.PubMedGoogle Scholar
- Ohtsuka Y, Lee J, Stamm DS, Sanderson IR. MIP-2 secreted by epithelial cells increases neutrophil and lymphocyte recruitment in the mouse intestine. Gut. 2001;49:526–33.PubMed CentralView ArticlePubMedGoogle Scholar
- Ikemori RY, Machado CML, Furuzawa KM, Nonogaki S, Osinaga E, Umezawa K, et al. Galectin-3 up-regulation in hypoxic and nutrient deprived microenvironments promotes cell survival. PLoS One. 2014;9:e111592.PubMed CentralView ArticlePubMedGoogle Scholar
- Vogel LA, Lester TL, Van Cleave VH, Metzger DW. Inhibition of murine B1 lymphocytes by interleukin-12. Eur J Immunol. 1996;26:219–23.View ArticlePubMedGoogle Scholar
- Chae BS, Shin TY. Immunoregulatory abnormalities of T cells and hyperreactivity of B cells in the in vitro immune response in pristane-induced lupus mice. Arch Pharm Res. 2007;30:191–8.View ArticlePubMedGoogle Scholar
- Calvani N, Caricchio R, Tucci M, Sobel ES, Silvestris F, Tartaglia P, et al. Induction of apoptosis by the hydrocarbon oil pristane: Implications for pristane-induced lupus. J Immunol. 2005;175:4777–82.View ArticlePubMedGoogle Scholar
- Janz S, Shacter E. Disposition of the plasmacytomagenic alkane pristane (2,6,10,14-tetramethylpentadecane) in mice. Cancer Biochem Biophys. 1995;15:25–34.PubMedGoogle Scholar